Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Culture clash: New diagnostics complicate public health surveillance
• Advisory council outlines progress, persisting issues in antibiotic resistance efforts
• CDC: ‘No longer any doubt’ Zika causes microcephaly, other birth defects
• CDC, OSHA issue guidelines on Zika protection in workplace
• Community-based HCV treatment lessens burden on specialists
• Electronic bottle caps show patients overstate adherence to antibiotics for SSTIs
• Failed HCV therapy increases risk for HCC
• FDA approves supplemental NDA for Viekira Pak for HCV genotype 1b
• High-dose HBV vaccine improves HIV patients’ long-term immune response
• Officials raise concerns over Zika during White House briefing
• PrEP uptake poised to grow as physicians gain insight, stigmas fade
• Senate committee recommends PATH Act for superbug treatments
• WHO: Humanitarian emergencies at ‘all-time high’
• WHO issues updated HCV treatment guidelines
• Experts discuss CIDTs and challenges of disease surveillance
• Challenges related to TB testing and diagnosis Juzar Ali, MD, FRCP(C), FCCP
• ASPs: Job of a steward, or time for a pilot? Donald Kaye, MD, MACP; Larry M. Bush, MD, FACP
• Outpatient clinic staff skip hand hygiene 37% of the time
• ACG issues new guideline on management of acute diarrhea infections
• Algebraic equation improves drug dosing in liver transplant patients
• CD4 testing in VA hospitals could be reduced by 30% without detriment
• Despite waning efficacy, influenza vaccine protects throughout season
• Ebola virus discovered after cleaning procedures in high isolation unit
• Fluoroquinolone administration route does not affect CAP outcomes
• ‘Forensic virology’ can trace patient history
• Formal sex education declines significantly among US adolescents
• Genetic study reveals dysentery’s global history
• Health workers identify motivators for OPV refusal in Pakistan
• Hypertension increases among HIV patients from 1996-2013
• IDSA, SHEA publish new recommendations for antibiotic stewardship programs
• Inconsistent infection control, isolation fuels hospital MERS outbreak
• Influenza vaccine effectiveness varies by type, subtype
• LARC users less likely to use condoms
• Mid-adult women remain at risk for incident, episodic HPV
• New mosquito traps offer nontoxic alternatives in Zika fight
• Norovirus gastroenteritis creates $60 billion global burden annually
• Parts of Florida, Texas face greatest risk for Zika virus
• Patients need safe environment to discuss sexual identity, potential risks
• Physicians lack clarity on FDA approvals, ‘breakthrough therapy’
• Plasma-derived HBV vaccine induces long-term protection
• Preventive isoniazid similar to empirical TB therapy among HIV patients initiating ART
• Researchers investigate early stages of HIV-neutralizing antibody
• Resistant E. coli, E. faecium CLABSIs prevalent among oncology settings
• Seasonal influenza vaccination during pregnancy reduces stillbirths
• Viruses’ biological features help to predict epidemics
• WHO’s six-step hand hygiene technique superior to CDC’s three-step technique
• Woman with rabies infection, no PEP delivers healthy baby in China
• Treatment reduces malaria incidence via blood transfusion in Ghana
• Bezlotoxumab helps to reduce CDI recurrence, hospital readmissions
• Chikungunya spreads to Turkish mosquitoes
• Coalition: Emerging diseases dictate need for extended R&D resources
• HPV vaccination increases among teens with health-seeking behaviors
• HSV-2 vaccine candidate reduces viral shedding, genital lesions up to 1 year
• Infections, scabies common among refugees seeking asylum in Switzerland, the Netherlands
• Long-term Sirturo therapy safe, effective against MDR-TB
• Neurological, psychiatric symptoms persist in Ebola survivors
• Omadacycline safe, effective treatment for skin infections
• Third phase 3 trial shows HEPLISAV-B vaccine safe, effective against HBV
• Zepatier safe, efficacious in general, problematic HCV patient populations
• Challenges in pediatric infectious diseases Leah Molloy, PharmD